Medtronic Financials

Market Capitalization $114.44 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	27.29
Forward PE	15.26
Price to Sales TTM	$3.51
Price to Book MRQ	$2.33
Enterprise to Revenue	4.07
Enterprise to EBITDA	14.71

Financial Reports as of Oct. 31, 2024

Financials

Fiscal Year Ends	2024-04-26
Most Recent Quarter	2024-10-31
Profit Margin	12.06%
Operating Margin	17.51%
Return on Assets TTM	4.42%
Return on Equity TTM	7.95%

Income Statement

Revenue TTM	$32,576,999,424
Revenue per Share TTM	$24.71
Quarterly Revenue Growth	2.80%
Gross Profit TTM	$21,346,000,896
EBITDA	$8,894,000,000
Net Income to Common TTM	$3,927,000,064
Diluted EPS TTM	$3.27
Quarterly Earnings Growth YoY	31.70%

Balance Sheet

Total Cash MRQ	$7,842,999,808
Total Cash per Share MRQ	$6.12
Total Debt MRQ	$
Total Debt to Equity MRQ	57.86
Current Ratio MRQ	2.13
Book Value per Share MRQ	$38.29

Cash Flow

Operating Cash Flow TTM	$6,897,999,872
Levered Free Cash Flow TTM	$4,904,750,080

MDT Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	1,282,290,048
Float Shares	1,280,387,209
Avg 10 Volume	8,650,970
Avg 30 Volume	None
Shares Short	10,177,612
Short Ratio	2.19
Short % of Shares	0.80%
% Held by Insiders	0.26%
% Held by Institutions	85.42%

Stock Price Summary

Beta	0.85
Fifty Two Week Low	$75.96
Fifty Two Week High	$92.68
Fifty Two Week Change	3.05%
Day 50 MA	$84.10
Day 200 MA	$84.20

Dividends and Splits

Forward Annual Dividend Rate	$2.80
Forward Annual Dividend Yield	3.10%
Trailing Annual Dividend Rate	$2.79
Trailing Annual Dividend Yield	3.09%
Payout Ratio	93.27%
Dividend Date	2025-01-10
Ex Dividend Date	2024-09-27
Last Split Factor
Last Split Date	1999-09-27